Hospital Universitario Fundacion Jimenez Diaz — Clinical Trial Site

774 Registered trials

312 Currently recruiting

Organisation

Hospital Universitario Fundacion Jimenez Diaz

Location

Madrid, Spain

Identifier

ORG-100028994

Address

Avenida De Los Reyes Catolicos 2, 28040, Spain

Departments

-
#03402 :Oncología
#11101:Neurology
#1703: Oncologia
#2006:Oncology
#2243; Nefrología
#2309:servicio de neurología
#2410: Neurología
#2504: Servicio de oncología
#2609: Urology
#3101:Oncología médica
#3277:Urologia
#4205:Servicio de Cardiología
#6001: Servicio Oncología
#6002:Oncología
#7002:Medical Oncology
#7005: Oncología Médica
#7017:Dermatología
034027: Oncología
1311: Hematología y Hemoterapia
1603 :Oncología
172415: Hematología
3008:Traumatología
3108: neurologia
3122: medicina interna
3312: Oncología
3604; Oncología Médica
4205: Cardiólogos
5512: Neumología
600 : Oncología
6004:Oncologia Médica
7001: Hematología y Hemoterapia
7002: Oncología
7003: Ensayos clínicos Hematología
7004: Phase I Clinical Trials Unit
7005: Oncología Medica
7012:Oncología Médica
7117:Oncología
7208: Neurology
724003:Oncología
9001: Hematología
Alergology
Allergy
Allergy Department
Calvo
Cardiología
Cardiology
Cardiology Department
Cirugía
Clinical Hematology
Coloproctología
Departamento de Ginecología
Department of Medical Oncology, Oncohealth Institute
department of Nephrology
Department of Oncology
Department of Ophthalmology, Fundación Jiménez Díaz University Hospita
Department of surgery
Dermatologia
Dermatology
Digestive
Digestive. Gastroenterology. Endoscopy.
Early Phase 1 UNIT
Early Phase Clinical Trial Unit
Endocrinology
Enfermedades Infecciosas
ES30010: Hematología y Hemoterapia
ESP001: Oncología
Fundacion Jimenez Diaz( #1)
Gastroenterologist
Gastroenterology
Gastroenterology and Hepatology
General and Digestive Surgery.
Ginecología
Gynecology
Gynecology Oncology
Haematology
Haematology and Hemotherapy
Haematology Service
Head of Immunization Department
Hematolgy
Hematología
Hematology
Hematology and Hemotherapy
Hematology and Hemotherapy Service
Hematology Department
hematology service
Hematololgy
Hospital Universitario Fundación Jiménez Díaz
Infectious department
Infectious disease
Infectious Diseases
Intensive Care medicine
Internal Medicine
Internal Medicine - Diabetioloy
Internal Medicine department-Infectious diseases
Internal Medicine Service
Lymphoma department
Lymphoma Unit
Medica Oncology
Medical Oncology
Medical Oncology Department
Medical Oncology Service
Medicina Nuclear
N/A
NA
Nefrologia
Nefrología e Hipertensión
Nefrology
Nephorogy Service
Nephrology
Nephrology and Hypertension Department
Nephrology Service
Neprology
NEUMOLOGÍA
Neumology
Neurología
Neurology
Neurology Department
Not applicable
Obstetrics and Gynecology
Oftalmologia
Onccology
Oncolgy
Oncologia
Oncología Médica
Oncología Radioterápica
Oncología, 504
Oncología, Unidad de Fase 1
Oncology
Oncology – Phase 1 Clinical Trials
Oncology & Hematology
Oncology Department
Oncology Medicine
Oncology Service
Oncology, Start Madrid-FJD, Hospital Fundacion Jimenez Diaz
Ophthalmology
Orthopaedic Surgery and Traumatology
Otorhinolaryngolog Service
Otorhinolaryngology
Pediatric Endocrinology
Pediatric Gastroenterologist
Pediatrics department
Peritoneal Oncology Surgery
Phase I Clinical Trials
Phase I Clinical Trials Unit
Pneumology
Preventive Medicine
Preventive medicine and public health service
Pulmonology
Research Facility
Respiratory medicine
Reumatología
Rheumatology
Servicio de Endocrinología y Nutrición
Servicio de Enfermedades Infecciosas
Servicio de Hamatologia
Servicio de Hematología
Servicio de Infecciosas
Servicio de Medicina Interna
Servicio de Medicina Preventiva
Servicio de Nefrología, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Servicio de Neumología
Servicio de Neurologia
Servicio de Oftalmologia
Servicio de Oncologia
Servicio de Oncología médica
Servicio de Otorrinolaringología
Servicio de Reumatología
Servicio de Urología
Servicio Enfermedades Infecciosas
Servicio oftalmologia
START
START - Madrid -FJD
START Madrid
START Madrid - FJD
Start Madrid - Phase I Unit
START Madrid FJD.Phase 1 Trials
START Madrid-FJD
START Madrid-FJD, Hospital Fundacion Jimenez Diaz
START Madrid-FJD, Phase I Clinical Trials Unit
Start Madrid-Hematology
Start Unit
Start_Oncology
START-FJD, Early Phase Clinical Trials Unit
Surgery and New Therapies Laboratory
Thoracic Oncology
Unidad de Enfermedades Infecciosas
Unidad de Ensayos Clínicos Fase I
Unidad de ensayos clínicos, fase 1
Unidad de Ensayos Fase I
Unidad Ensayos Fase I - Oncology
Unidad START-Madrid FJD
Urologia
Urology

Clinical trials at this site (774)

Search interface

Feasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma Under evaluation

2024-514991-41-01 Upper Tract Urothelial Carcinoma. Upper urinary tract t 4
KISIMA-02 vaccine-based immunotherapy for patients with mutated pancreatic cancer Not authorised

2022-501854-12-00 KRAS G12D/G12V Mutated Pancreatic Ductal Adenocarcinoma 1
A Phase IIIb, Single Arm, Open-label, Multicentre Study of Durvalumab in Combination with Chemotherapy for the First Line Treatment for Pati… Not authorised

2022-502043-35-00 Advanced Biliary Tract Cancers 5
A clinical study of people with HIV-1 who have not taken antiretroviral therapy, one group will start treatment with a combination of doravi… Not authorised

2022-502099-22-00 HIV-1 Infection 5
A clinical study of people with HIV-1 who received prior treatment combination of doravirine and islatravir Not authorised

2022-502126-40-00 HIV-1 infection 5
A clinical study of people with HIV-1 who take antiretroviral therapy and switch their treatment to a combination of doravirine and islatrav… Not authorised

2022-502127-22-00 HIV-1 Infection 5
A Phase 1/Phase 2 Trial to Evaluate Safety, Immunogenicity and PSA Response of VTP-850 Prostate Cancer Immunotherapeutic in Men with Biochem… Not authorised

2023-504066-39-00 Prostate Cancer 7
Study BT8009-230 in Subjects with Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) Not authorised

2023-504231-41-00 Locally advanced or metastatic urothelial cancer 10
HARMONi-3 Not authorised

2023-504989-37-00 Metastatic Squamous Non-small Cell Lung Cancer 5
Safety, tolerability, and efficacy of mFOLFIRINOX ±BNT321 as adjuvant therapy following curative resection in patients with pancreatic adeno… Not authorised

2023-506014-47-00 Resected (R0 or R1) pancreatic ductal adenocarcinoma 9
A study to test a new immunotherapy, ABX-001, alone and in combination with the marketed drug, pembrolizumab, for the treatment of tumors pr… Not authorised

2024-512403-39-00 Advanced Solid Tumors Who Are Beyond Standard of Care 1
Effect of Copper CU64 PSMA I&T scanning to detect potential disease spread to lymph nodes in men with newly diagnosed Prostate Cancer Not authorised

2024-512754-16-00 Prostate cancer 5
Clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas Not authorised

2024-514827-40-00 Patients with advanced soft-tissue sarcoma (leiomyosarc 9
A trial to learn how ceralasertib affects the way certain medications move throughout the body over time and how safe it is to use ceralaser… Not authorised

2024-516611-24-00 Advanced solid tumour 3
PHASE I/IIa CLINICAL TRIAL FOR THE TREATMENT OF GRAFT VERSUS HOST DISEASE WITH A NEW GENERATION OF MESENCHYMAL STROMAL CELLS ECTOPICALLY EXP… Not authorised

2025-523139-21-00 Patients who have developed acute GVHD refractory to co 9
A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown

2025-523766-25-00 Ulcerative colitis 5
A trial to learn how well Dato-DXd and rilvegostomig work and how safe they are in participants with stage I adenocarcinoma non-small cell l… Pending

2024-512195-35-00 Stage I adenocarcinoma non-small cell lung cancer (NSCL 5
Study to assess the safety and efficacy of multipotent mesenchymal stem cells administration as a treatment for patients with faecal inconti… Pending

2024-515766-13-00 Fecal incontinence 4
A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti_Tumor Activity of AVZO-02… Pending

2024-517339-30-00 Advanced Solid Tumors 7
A study to test the safety and effects of IOMX-0675, an antibody treatment, alone or with pembrolizumab, in patients with advanced or spread… Pending

2024-517449-14-00 Advanced/metastatic solid tumors 1
FIRST IN HUMAN PHASE 1 DOSE ESCALATION AND EXPANSION CLINICAL TRIAL TO EVALUATE THE SAFETY, PHARMACOKINETICS AND ANTITUMOR ACTIVITY OF INTR… Pending

2024-517569-18-00 Patients with advanced refractory solid tumors. 1
A Phase III study evaluating the efficacy of atezoliumab administration in addition to BCG (Bacillus Calmette-Guerin) for 1 year in patient… Pending

2024-517621-54-00 High-risk non-muscle invasive bladder cancer (NMIBC) af 5
Atezolizumab, Pertuzumab and Trastuzumab with chemotherapy as neoadjuvant treatment of HER2 positive early high-risk and locally advanced br… Pending

2024-518026-32-00 Invasive Breast Cancer 5
Phase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus RAdiotherapy in Soft Tissue Sarcoma pat… Pending

2024-518199-30-00 Soft tissue sarcoma patients 9